Skip to main content
. 2018 Nov 18;96(2):134–142. doi: 10.1002/cyto.b.21745

Figure 3.

Figure 3

Percentage CD123 positive cells (CD123‐PPC) for AML, BCP‐ALL, and T‐ALL patients. Percentage CD123 positive cells based on 739 intensity cut‐off. Black lines visualize pediatric patients and gray lines visualize adult patients. Gray area visualizes the difference between pediatric and adult patients (reported P‐values based on a Mann–Whitney U tests). Other immunophenotyping studies typically state “at least … patients have at least … percent positive cells.” As different studies use different percentages, we have chosen for this visualization, which allows lookup of any combination. For example, approximately 65% of pediatric AML patients have at least 60% CD123 positive cells based on the 739 positivity cut‐off. (A) CD123‐PPC for AML, BCP‐ALL and T‐ALL patients. (B) CD123‐PPC for selected AML subgroups. (C) CD123‐PPC for selected BCP‐ALL subgroups.